(Q39396204)

English

Carbon anhydrase IX specific immune responses in patients with metastatic renal cell carcinoma potentially cured by interleukin-2 based immunotherapy.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23802595%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Carbon anhydrase IX specific immune responses in patients with metastatic renal cell carcinoma potentially cured by interleukin-2 based immunotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23802595%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

0 references

1 reference

based on heuristic

inferred from title

renal cell carcinoma

1 reference

based on heuristic

inferred from title

metastatic renal cell carcinoma

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23802595%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23802595%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23802595%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Susanne Rasmussen

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23802595%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Johannes W Pedersen

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23802595%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Peter Braendstrup

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23802595%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Mogens H Claesson

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23802595%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Anders Elm Pedersen

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23802595%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Mikkel Harndahl

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23802595%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

publication date

27 June 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23802595%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Immunopharmacology and Immunotoxicology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23802595%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

35

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23802595%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23802595%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

487-496

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23802595%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Raising the bar: the curative potential of human cancer immunotherapy.

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2013.802802

21 January 2018

Targeted therapy for advanced renal cell cancer (RCC): a Cochrane systematic review of published randomised trials

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2013.802802

21 January 2018

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2013.802802

21 January 2018

Clinical and molecular prognostic factors in renal cell carcinoma: what we know so far.

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2013.802802

21 January 2018

Indium-111-labeled girentuximab immunoSPECT as a diagnostic tool in clear cell renal cell carcinoma

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2013.802802

21 January 2018

Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2013.802802

21 January 2018

Renal-cell carcinoma: tumour markers, T-cell epitopes, and potential for new therapies

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2013.802802

21 January 2018

Prognostic impact of carbonic anhydrase IX expression in human renal cell carcinoma

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2013.802802

21 January 2018

CA9 gene: single nucleotide polymorphism predicts metastatic renal cell carcinoma prognosis

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2013.802802

21 January 2018

Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer.

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2013.802802

21 January 2018

Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear-cell renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2013.802802

21 January 2018

Impact of immune parameters on long-term survival in metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2013.802802

21 January 2018

Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2013.802802

21 January 2018

Peptide binding to HLA class I molecules: homogenous, high-throughput screening, and affinity assays.

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2013.802802

21 January 2018

CTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, and HLA-wide screening.

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2013.802802

21 January 2018

Generation of kidney cancer-specific antitumor immune responses using peripheral blood monocytes transduced with a recombinant adenovirus encoding carbonic anhydrase 9.

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2013.802802

21 January 2018

The tumor antigens RHAMM and G250/CAIX are expressed in head and neck squamous cell carcinomas and elicit specific CD8+ T cell responses.

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2013.802802

21 January 2018

A phase I trial of vaccination of CA9-derived peptides for HLA-A24-positive patients with cytokine-refractory metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2013.802802

21 January 2018

Evaluation of genetic susceptibility loci for chronic hepatitis B in Chinese: two independent case-control studies

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2013.802802

21 January 2018

The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2013.802802

21 January 2018

Comprehensive analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci and squamous cell cervical cancer risk

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2013.802802

21 January 2018

Carbonic Anhydrase IX as an Anticancer Therapy Target: Preclinical Evaluation of Internalizing Monoclonal Antibody Directed to Catalytic Domain

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2013.802802

21 January 2018

Intratumoural and peripheral blood lymphocyte subsets in patients with metastatic renal cell carcinoma undergoing interleukin-2 based immunotherapy: association to objective response and survival

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2013.802802

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39396204&oldid=1531340822"